Brian Bender and Santosh Adhikari distinguish Isomorphic Labs' specialised drug-discovery models from general-purpose models used to coordinate surrounding research work. The examples focus on reading and structuring information, rather than demonstrating a newly discovered medicine.
Santosh Adhikari describes asking Gemini 4 to synthesise academic papers about a protein target, connect ideas across fields and produce a research report. Santosh Adhikari reports a turnaround of roughly 10 to 15 minutes for work that would otherwise take one or two days; this is a researcher account, not an independently measured benchmark.
Brian Bender describes testing Gemini 4 on familiar chemistry patents, where molecular structures and experimental results can be separated by dozens of pages. Brian Bender says the model extracted information into a spreadsheet and generated reports, with ten patents processed in an afternoon rather than roughly a month. The video presents these observations as early research assistance, not proof of clinical efficacy.
Watch on YouTube
